A meta-analysis of randomized and controlled trials among NAFLD adult patients testing the impact of vitamin E supplementation alone on the serum levels of aminotransferases AST and ALT showed that vitamin E supplementation ranging from 400 IU (268 mg) to 800 IU (536 mg) consistently reduced serum ALT and AST levels compared with a placebo, with the effect being more prominent in the ALT levels. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.